Related Experiment Video
Updated: May 1, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Use of CPAP and surfactant therapy in newborns with respiratory distress syndrome
Srinivas Murki1, Ashok Deorari, Dharmapuri Vidyasagar
1Department of Pediatrics, Fernandez Hospital, Hyderabad, India.
Insights
Respiratory distress syndrome (RDS) management in developing nations relies on early continuous positive airway pressure (CPAP) and surfactant therapy. Improving access to these interventions and preventive measures like antenatal steroids can significantly reduce infant mortality.
Area of Science:
- Neonatal Medicine
- Pediatric Critical Care
Background:
- Respiratory distress syndrome (RDS) poses a significant health challenge in developing countries.
- Effective interventions like continuous positive airway pressure (CPAP) and surfactant therapy are crucial for managing RDS.
Purpose of the Study:
- To highlight the importance of early CPAP and selective surfactant administration for RDS management.
- To recommend preventive strategies and infrastructure development for neonatal care in developing countries.
Main Methods:
- Review of current evidence supporting CPAP and surfactant therapies.
- Analysis of recommended preventive measures including institutional deliveries and antenatal steroid coverage.
- Emphasis on training healthcare professionals for specialized neonatal units.
Main Results:
- Early CPAP and selective surfactant administration are highly effective for RDS.
- Increased institutional deliveries and antenatal steroid use are vital preventive measures.
- Training for nursing staff and pediatricians is essential for implementing advanced therapies.
Conclusions:
- Optimizing care for preterm infants with RDS requires implementing CPAP and surfactant therapies.
- Strengthening neonatal care units and training personnel are key to reducing RDS mortality and morbidity.
- A multi-faceted approach combining early intervention and prevention is necessary for better neonatal outcomes.
Abstract:
Respiratory distress syndrome (RDS) is a major disease burden in the developing countries. Current evidence supports early continuous positive airway pressure (CPAP) use and early selective surfactant administration as the most efficacious interventions in the management of RDS, both in developed and developing countries. In developing countries, it is recommended to increase institutional deliveries and increase the coverage of antenatal steroids in women in preterm labor as preventive measures. Establishing intervention of CPAP and surfactant therapies in the Level II special care newborn units (SCNUs) and Level III units requires focus on training nursing staff and pediatricians across the board. These approaches would pave the way in optimizing the care of the preterm infants with RDS and decrease their mortality and morbidity significantly.
More Related Videos
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Breathing
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Acute Respiratory Failure-III
Cardiopulmonary Resuscitation II: ACLS Airway Management
Pulmonary Cycle: Exhalation